000 01369 a2200433 4500
005 20250513193037.0
264 0 _c19991217
008 199912s 0 0 eng d
022 _a0968-5243
024 7 _a10.1007/BF02594595
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPort, M
245 0 0 _aP760 and P775: MRI contrast agents characterized by new pharmacokinetic properties.
_h[electronic resource]
260 _bMagma (New York, N.Y.)
_cAug 1999
300 _a172-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aContrast Media
_xpharmacokinetics
650 0 4 _aHalf-Life
650 0 4 _aHeterocyclic Compounds
_xblood
650 0 4 _aImage Enhancement
650 0 4 _aMagnetic Resonance Angiography
_xmethods
650 0 4 _aMagnetic Resonance Imaging
_xmethods
650 0 4 _aModels, Biological
650 0 4 _aOrganometallic Compounds
_xblood
650 0 4 _aRabbits
700 1 _aMeyer, D
700 1 _aBonnemain, B
700 1 _aCorot, C
700 1 _aSchaefer, M
700 1 _aRousseaux, O
700 1 _aSimonot, C
700 1 _aBourrinet, P
700 1 _aBenderbous, S
700 1 _aDencausse, A
700 1 _aDevoldere, L
773 0 _tMagma (New York, N.Y.)
_gvol. 8
_gno. 3
_gp. 172-6
856 4 0 _uhttps://doi.org/10.1007/BF02594595
_zAvailable from publisher's website
999 _c10461137
_d10461137